Your browser doesn't support javascript.
loading
Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers.
Martinez Chanza, Nieves; Werner, Lillian; Plimack, Elizabeth; Yu, Evan Y; Alva, Ajjai S; Crabb, Simon J; Powles, Thomas; Rosenberg, Jonathan E; Baniel, Jack; Vaishampayan, Ulka N; Berthold, Dominik R; Ladoire, Sylvain; Hussain, Syed A; Milowsky, Matthew I; Agarwal, Neeraj; Necchi, Andrea; Pal, Sumanta K; Sternberg, Cora N; Bellmunt, Joaquim; Galsky, Matthew D; Harshman, Lauren C.
Afiliação
  • Martinez Chanza N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Werner L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Plimack E; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Yu EY; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Alva AS; University of Michigan, Ann Arbor, MI, USA.
  • Crabb SJ; University of Southampton, Southampton, UK.
  • Powles T; Barts Cancer Institute, London, UK.
  • Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Baniel J; Rabin Medical Center, Petah Tivka, Israel.
  • Vaishampayan UN; Karmanos Cancer Institute, Detroit, MI, USA.
  • Berthold DR; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Ladoire S; Georges François Leclerc Cancer Center, Dijon, France.
  • Hussain SA; Clatterbridge Cancer Centre, Liverpool, UK.
  • Milowsky MI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Agarwal N; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.
  • Necchi A; Istituto Nazionale Tumori of Milan, Milano, MI, Italy.
  • Pal SK; City of Hope, Duarte, CA, USA.
  • Sternberg CN; San Camillo-Forlanini Hospital, Rome, Italy.
  • Bellmunt J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Galsky MD; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Harshman LC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: LaurenC_Harshman@dfci.harvard.edu.
Eur Urol Oncol ; 3(5): 671-679, 2020 10.
Article em En | MEDLINE | ID: mdl-31411990
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Recidiva Local de Neoplasia Tipo de estudo: Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Recidiva Local de Neoplasia Tipo de estudo: Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos